Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
International Journal of Colorectal Disease|February 5, 2013
Neuroendocrine markers and psychological features in patients with irritable bowel syndromeCristina Stasi, Massimo Bellini, Francesco Costa, et al.Journal of Hepatology|November 28, 2006
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient miceElena Zamara, Sara Galastri, Sara Aleffi, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|September 10, 2005
Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cellsRoberto G Romanelli, Ilaria Petrai, Gaia Robino, et al.Journal of Hepatology|June 28, 2011
Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practiceFrancesco Salerno, Massimo Cazzaniga, Manuela Merli, et al.Gastroenterology|October 1, 2003
The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis CAndrea Bonacchi, Ilaria Petrai, Raffaella M S Defranco, et al.Asian Journal of Psychiatry|October 17, 2015
Screening of distress among hospitalized patients in a department of internal medicineMassimo Rosselli, Maria Vittoria Salimbeni, Caterina Bessi, et al.The American Journal of Pathology|December 7, 2006
Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cellsCristiana Bertolani, Pau Sancho-Bru, Paola Failli, et al.Journal of Hepatology|August 28, 2020
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascitesPaolo Caraceni, Manuel Tufoni, Giacomo Zaccherini, et al.Research and Practice in Thrombosis and Haemostasis|September 23, 2024
Oxidative stress-induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular riskStefano Gitto, Claudia Fiorillo, Flavia Rita Argento, et al.Liver Cancer|May 12, 2021
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationClaudia Campani, Alessandro Vitale, Gabriele Dragoni, et al.Pageof 8